- Home
- TBN vs TAK Comparison
TBN vs TAK Comparison
Compare TBN & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBN
- TAK
- Stock Information
- Founded
- TBN 2009
- TAK 1781
- Country
- TBN Australia
- TAK Japan
- Employees
- TBN N/A
- TAK N/A
- Industry
- TBN
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- TBN
- TAK Health Care
- Exchange
- TBN NYSE
- TAK Nasdaq
- Market Cap
- TBN 43.4B
- TAK 47.5B
- IPO Year
- TBN 2024
- TAK N/A
- Fundamental
- Price
- TBN $19.76
- TAK $14.48
- Analyst Decision
- TBN Buy
- TAK
- Analyst Count
- TBN 3
- TAK 0
- Target Price
- TBN $35.67
- TAK N/A
- AVG Volume (30 Days)
- TBN 26.9K
- TAK 3.1M
- Earning Date
- TBN 09-19-2025
- TAK 07-30-2025
- Dividend Yield
- TBN N/A
- TAK 3.75%
- EPS Growth
- TBN N/A
- TAK N/A
- EPS
- TBN N/A
- TAK 0.45
- Revenue
- TBN N/A
- TAK $30,595,075,281.00
- Revenue This Year
- TBN N/A
- TAK $1.01
- Revenue Next Year
- TBN N/A
- TAK $1.04
- P/E Ratio
- TBN N/A
- TAK $64.59
- Revenue Growth
- TBN N/A
- TAK 7.45
- 52 Week Low
- TBN $15.75
- TAK $12.80
- 52 Week High
- TBN $34.50
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- TBN N/A
- TAK 41.31
- Support Level
- TBN N/A
- TAK $14.41
- Resistance Level
- TBN N/A
- TAK $14.86
- Average True Range (ATR)
- TBN 0.00
- TAK 0.19
- MACD
- TBN 0.00
- TAK -0.04
- Stochastic Oscillator
- TBN 0.00
- TAK 13.89
About TBN TAMBORAN RESOURCES CORPORATION
Tamboran Resources Corp is a gas company focused on supporting the Net Zero CO2 energy transition in Australia and Asia-Pacific through developing low CO2 unconventional gas resources in the Australian Northern Territory.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.